Variation_Name | GeneID | GeneSymbol | ClinicalSignificance | dbSNP | RCVaccession | TestedInGTR | PhenotypeIDs | Chromosome | Start | Stop | HGVS_c | HGVS_p | HGVS_g | OtherIDs | Disease_ClinVar | Disease_hgmd | NM_014363.5(SACS):c.13527dupA (p.Glu4510Argfs) | 26278 | SACS | Pathogenic | 797045936 | RCV000194514; | N | MedGen:C1849140,OMIM:270550,ORPHA:98 | 13 | 23904488 | 23904488 | NM_014363.5:c.13527dupA | NP_055178.3:p.Glu4510Argfs | NC_000013.10:g.23904488dupT | - | C1849140 270550 Spastic ataxia Charlevoix-Saguenay type | | |
NM_014363.5(SACS):c.12973C>T (p.Arg4325Ter) | 26278 | SACS | Likely pathogenic | 762947018 | RCV000169272; | N | MedGen:C1849140,OMIM:270550,ORPHA:98 | 13 | 23905042 | 23905042 | NM_014363.5:c.12973C>T | NP_055178.3:p.Arg4325Ter | NC_000013.10:g.23905042G>A | - | C1849140 270550 Spastic ataxia Charlevoix-Saguenay type | | |
NM_014363.5(SACS):c.12851_12854delAGAG (p.Glu4284Alafs) | 26278 | SACS | Likely pathogenic | 786204628 | RCV000169401; | N | MedGen:C1849140,OMIM:270550,ORPHA:98 | 13 | 23905161 | 23905164 | NM_014363.5:c.12851_12854delAGAG | NP_055178.3:p.Glu4284Alafs | NC_000013.10:g.23905161_23905164delCTCT | - | C1849140 270550 Spastic ataxia Charlevoix-Saguenay type | | |
NM_014363.5(SACS):c.12232C>T (p.Arg4078Ter) | 26278 | SACS | Likely pathogenic | 141315518 | RCV000169220; | N | MedGen:C1849140,OMIM:270550,ORPHA:98 | 13 | 23905783 | 23905783 | NM_014363.5:c.12232C>T | NP_055178.3:p.Arg4078Ter | NC_000013.10:g.23905783G>A | - | C1849140 270550 Spastic ataxia Charlevoix-Saguenay type | | |
NM_014363.5(SACS):c.12220G>C (p.Ala4074Pro) | 26278 | SACS | Pathogenic | 137853016 | RCV000005849; | N | MedGen:C1849140,OMIM:270550,ORPHA:98 | 13 | 23905795 | 23905795 | NM_014363.5:c.12220G>C | NP_055178.3:p.Ala4074Pro | NC_000013.10:g.23905795C>G | OMIM Allelic Variant:604490.0003 | C1849140 270550 Spastic ataxia Charlevoix-Saguenay type | | |
NM_014363.5(SACS):c.12160C>T (p.Gln4054Ter) | 26278 | SACS | Pathogenic | 281865120 | RCV000032008; | N | MedGen:C1849140,OMIM:270550,ORPHA:98 | 13 | 23905855 | 23905855 | NM_014363.5:c.12160C>T | NP_055178.3:p.Gln4054Ter | NC_000013.10:g.23905855G>A | - | C1849140 270550 Spastic ataxia Charlevoix-Saguenay type | | |
NM_014363.5(SACS):c.11624G>A (p.Arg3875His) | 26278 | SACS | Likely pathogenic | 863224916 | RCV000197883; | N | MedGen:C1849140,OMIM:270550,ORPHA:98 | 13 | 23906391 | 23906391 | NM_014363.5:c.11624G>A | NP_055178.3:p.Arg3875His | NC_000013.10:g.23906391C>T | - | C1849140 270550 Spastic ataxia Charlevoix-Saguenay type | | |
NM_014363.5(SACS):c.10907G>A (p.Arg3636Gln) | 26278 | SACS | Pathogenic | 281865119 | RCV000032007; | N | MedGen:C1849140,OMIM:270550,ORPHA:98 | 13 | 23907108 | 23907108 | NM_014363.5:c.10907G>A | NP_055178.3:p.Arg3636Gln | NC_000013.10:g.23907108C>T | - | C1849140 270550 Spastic ataxia Charlevoix-Saguenay type | | |
NM_014363.5(SACS):c.10906C>T (p.Arg3636Ter) | 26278 | SACS | Pathogenic | 780247476 | RCV000192438; | N | MedGen:C1849140,OMIM:270550,ORPHA:98 | 13 | 23907109 | 23907109 | NM_014363.5:c.10906C>T | NP_055178.3:p.Arg3636Ter | NC_000013.10:g.23907109G>A | - | C1849140 270550 Spastic ataxia Charlevoix-Saguenay type | | |
NM_014363.5(SACS):c.10466_10467delCT (p.Ser3489Leufs) | 26278 | SACS | Likely pathogenic | 786204416 | RCV000168999; | N | MedGen:C1849140,OMIM:270550,ORPHA:98 | 13 | 23907548 | 23907549 | NM_014363.5:c.10466_10467delCT | NP_055178.3:p.Ser3489Leufs | NC_000013.10:g.23907548_23907549delAG | - | C1849140 270550 Spastic ataxia Charlevoix-Saguenay type | | |
NM_014363.5(SACS):c.9742T>C (p.Trp3248Arg) | 26278 | SACS | Pathogenic | 137853018 | RCV000005854; | N | MedGen:C1849140,OMIM:270550,ORPHA:98 | 13 | 23908273 | 23908273 | NM_014363.5:c.9742T>C | NP_055178.3:p.Trp3248Arg | NC_000013.10:g.23908273A>G | OMIM Allelic Variant:604490.0008 | C1849140 270550 Spastic ataxia Charlevoix-Saguenay type | | |
NM_014363.5(SACS):c.8848_8849dupCA (p.Val2951Metfs) | 26278 | SACS | Likely pathogenic | 797044608 | RCV000194102; | N | MedGen:C1849140,OMIM:270550,ORPHA:98 | 13 | 23909166 | 23909167 | NM_014363.5:c.8848_8849dupCA | NP_055178.3:p.Val2951Metfs | NC_000013.10:g.23909166_23909167dupTG | - | C1849140 270550 Spastic ataxia Charlevoix-Saguenay type | | |
NM_014363.5(SACS):c.8844delT (p.Ile2949Phefs) | 26278 | SACS | Pathogenic | 281865117 | RCV000005847; | N | MedGen:C1849140,OMIM:270550,ORPHA:98 | 13 | 23909171 | 23909171 | NM_014363.5:c.8844delT | NP_055178.3:p.Ile2949Phefs | NC_000013.10:g.23909171delA | GeneReviews:NBK1255,OMIM Allelic Variant:604490.0001 | C1849140 270550 Spastic ataxia Charlevoix-Saguenay type | | |
NM_014363.5(SACS):c.8542_8543delTT (p.Phe2848Profs) | 26278 | SACS | Pathogenic | -1 | RCV000218042; | N | MedGen:C1849140,OMIM:270550,ORPHA:98 | 13 | 23909472 | 23909473 | NM_014363.5:c.8542_8543delTT | NP_055178.3:p.Phe2848Profs | | - | C1849140 270550 Spastic ataxia Charlevoix-Saguenay type | | |
NM_014363.5(SACS):c.8393C>A (p.Pro2798Gln) | 26278 | SACS | Likely pathogenic | 140551762 | RCV000194652; | N | MedGen:C1849140,OMIM:270550,ORPHA:98 | 13 | 23909622 | 23909622 | NM_014363.5:c.8393C>A | NP_055178.3:p.Pro2798Gln | NC_000013.10:g.23909622G>T | - | C1849140 270550 Spastic ataxia Charlevoix-Saguenay type | | |
NM_014363.5(SACS):c.7641dupA (p.Glu2548Argfs) | 26278 | SACS | Pathogenic | -1 | RCV000214078; | N | MedGen:C1849140,OMIM:270550,ORPHA:98 | 13 | 23910374 | 23910374 | NM_014363.5:c.7641dupA | NP_055178.3:p.Glu2548Argfs | | - | C1849140 270550 Spastic ataxia Charlevoix-Saguenay type | | |
NM_014363.5(SACS):c.7504C>T (p.Arg2502Ter) | 26278 | SACS | Pathogenic | 281865118 | RCV000005848; | N | MedGen:C1849140,OMIM:270550,ORPHA:98 | 13 | 23910511 | 23910511 | NM_014363.5:c.7504C>T | NP_055178.3:p.Arg2502Ter | NC_000013.10:g.23910511G>A | OMIM Allelic Variant:604490.0002 | C1849140 270550 Spastic ataxia Charlevoix-Saguenay type | | |
NM_014363.5(SACS):c.7276C>T (p.Arg2426Ter) | 26278 | SACS | Likely pathogenic | 786204750 | RCV000169603; RCV000197883; | N | MedGen:C1849140,OMIM:270550,ORPHA:98 | 13 | 23910739 | 23910739 | NM_014363.5:c.7276C>T | NP_055178.3:p.Arg2426Ter | NC_000013.10:g.23910739G>A | - | C1849140 270550 Spastic ataxia Charlevoix-Saguenay type | | |
NM_014363.5(SACS):c.7276C>T (p.Arg2426Ter) | 26278 | SACS | Likely pathogenic | 786204750 | RCV000169603; RCV000197883; | N | MedGen:C1849140,OMIM:270550,ORPHA:98 | 13 | 23910739 | 23910739 | NM_014363.5:c.7276C>T | NP_055178.3:p.Arg2426Ter | NC_000013.10:g.23910739G>A | - | C1849140 270550 Spastic ataxia Charlevoix-Saguenay type | | |
NM_014363.5(SACS):c.5836T>C (p.Trp1946Arg) | 26278 | SACS | Pathogenic | 137853017 | RCV000005852; | N | MedGen:C1849140,OMIM:270550,ORPHA:98 | 13 | 23912179 | 23912179 | NM_014363.5:c.5836T>C | NP_055178.3:p.Trp1946Arg | NC_000013.10:g.23912179A>G | OMIM Allelic Variant:604490.0006 | C1849140 270550 Spastic ataxia Charlevoix-Saguenay type | | |
NM_014363.5(SACS):c.4033dupC (p.Gln1345Profs) | 26278 | SACS | Pathogenic | 606231163 | RCV000005853; | N | MedGen:C1849140,OMIM:270550,ORPHA:98 | 13 | 23913982 | 23913982 | NM_014363.5:c.4033dupC | NP_055178.3:p.Gln1345Profs | NC_000013.10:g.23913982dupG | OMIM Allelic Variant:604490.0007 | C1849140 270550 Spastic ataxia Charlevoix-Saguenay type | | |
NM_014363.5(SACS):c.3589T>C (p.Ser1197Pro) | 26278 | SACS | Likely pathogenic | 727503785 | RCV000157061; | N | MedGen:C1849140,OMIM:270550,ORPHA:98 | 13 | 23914426 | 23914426 | NM_014363.5:c.3589T>C | NP_055178.3:p.Ser1197Pro | NC_000013.10:g.23914426A>G | - | C1849140 270550 Spastic ataxia Charlevoix-Saguenay type | | |
NM_014363.5(SACS):c.3328dupA (p.Ile1110Asnfs) | 26278 | SACS | Likely pathogenic | 773840580 | RCV000169583; | N | MedGen:C1849140,OMIM:270550,ORPHA:98 | 13 | 23914687 | 23914687 | NM_014363.5:c.3328dupA | NP_055178.3:p.Ile1110Asnfs | NC_000013.10:g.23914687dupT | - | C1849140 270550 Spastic ataxia Charlevoix-Saguenay type | | |
NM_014363.5(SACS):c.3161T>C (p.Phe1054Ser) | 26278 | SACS | Pathogenic | 137853019 | RCV000005855; | N | MedGen:C1849140,OMIM:270550,ORPHA:98 | 13 | 23914854 | 23914854 | NM_014363.5:c.3161T>C | NP_055178.3:p.Phe1054Ser | NC_000013.10:g.23914854A>G | OMIM Allelic Variant:604490.0009 | C1849140 270550 Spastic ataxia Charlevoix-Saguenay type | | |
NM_014363.5(SACS):c.2439_2440delAT (p.Val815Glyfs) | 26278 | SACS | Likely pathogenic | 775059063 | RCV000169208; | N | MedGen:C1849140,OMIM:270550,ORPHA:98 | 13 | 23915575 | 23915576 | NM_014363.5:c.2439_2440delAT | NP_055178.3:p.Val815Glyfs | NC_000013.10:g.23915575_23915576delAT | - | C1849140 270550 Spastic ataxia Charlevoix-Saguenay type | | |
NM_014363.5(SACS):c.1919_1920delAC (p.His640Profs) | 26278 | SACS | Pathogenic | 797045937 | RCV000192515; | N | MedGen:C1849140,OMIM:270550,ORPHA:98 | 13 | 23928831 | 23928832 | NM_014363.5:c.1919_1920delAC | NP_055178.3:p.His640Profs | NC_000013.10:g.23928831_23928832delGT | - | C1849140 270550 Spastic ataxia Charlevoix-Saguenay type | | |